It is puncture itself that causes risk.” That is a quote from H.C. Jacobaeus, the first person to perform a laparoscopic surgery on a human. Over a century after Jacobaeus said this we are still grappling with surgical complications from punctures. Trocar insertion errors, for example, account for the largest number of complications related to laparoscopic surgery. Nikolai Begg, a PhD student in mechanical engineering at MIT, hopes that his novel device – a “flexure-based puncture access mechanism” - will take the danger out of procedures that Begg likens to drilling through a piece of wood or inserting a straw into a Capri Sun drink to his TEDxBeaconStreet talk.

...
July 16th, 2014
0

Germany has more to brag about than a World Cup championship (thanks to a late-game goal that put the nail in Argentina's coffin in the final). The country is also home to a thriving medical device industry showing impressive strength in all areas ranging from R&D and medtech startups to regulation and market growth. While the eurozone crisis and global recession crippled some countries and brought others to their knees, fiscally conservative Germany has weathered the storm and maintained a growing healthcare sector.
 
Here are some of the must-read stories on the trends and companies that are marking Germany's medical device industry.
 
 
What's Germany's Secret?
 
What...
July 14th, 2014
0

St. Jude Medical's CardioMEMS acquisition brought to the Minnesota device a breakthrough heart monitoring device meant to serve as an early alert system for chronic heart failure patients. The FDA recently cleared it.

The CardioMEMS implantable sensor

In a clinical trial of 550 patients, the CardioMEMS system, the world...

July 14th, 2014
0

The decision may further narrow the situations where patent holders may assert a claim of induced infringement in the medical device space. 

By Jeremy Lowe

In a unanimous opinion delivered June 2, 2014, the Supreme Court decided that Internet content delivery company Limelight Technologies Inc. was not liable for induced infringement of Akamai Technologies’ content delivery patents. Justice Samuel Alito, writing on behalf of the court, declared that the Federal Circuit “fundamentally misunderstands what it means to infringe a method patent” and held that there can be no induced infringement without direct infringement. Direct infringement, in the Supreme Court’s formulation...

July 10th, 2014
0

Medical device companies will have to pay more attention during patent procurement to precisely defining their inventions.

By Jeremy Lowe

 

On June 2, 2014, the Supreme Court ruled unanimously in Nautilus Inc. v. Biosig Instruments Inc. that Biosig Instruments’ heart-rate monitor patent was invalid. Biosig had sued Nautilus Inc., its competitor, for allegedly infringing the patented monitor, and the District Court and the Court of Appeals for the Federal Circuit found that the patent was valid in favor of Biosig. Writing for the high court, Justice Ruth Bader Ginsburg disagreed with the lower courts’ rulings, saying the claimed “spaced relationship” design in Biosig’s patent may well be too...

July 9th, 2014
0

America is a nation of choice.

Especially to someone who can remember only two government-controlled TV channels as a pre-teen in India in the 1980s, the choice that we as Americans have not only in terms of the idiot box, but everything else, is sometimes dizzying.

That choice has become even more widespread with advances in technology. We are forever making choices. We are constantly opting in and out. 

Except when it comes to healthcare. There, no matter what we would prefer, we are held fast to HIPAA. Imagine being only allowed to communicate using feather quills and ink while email and texting were readily available. 

Now Dr. Mark Blatt, Intel's Worldwide Medical Director, is expounding a radical though rational idea. Let patients decide whether they want to opt out of HIPAA guidelines. Blatt recently...

July 9th, 2014
1

A Medtronic executive turned a few heads recently when he told MassDevice.com that when it comes to rivals, the medical technology company sees Google as its biggest challenger in the coming years.

That's right. Not Johnson & Johnson. Not Boston Scientific. And no, not Apple either, but the search giant Google.

While surprising, the statement is not completely coming out of left field. Experts have been talking about how Silicon Valley is poised to disrupt healthcare and medtech. There are plenty of examples of nontraditional firms innovating in healthcare these days.

Google itself is developing a...

July 8th, 2014
0

If there's one takeaway from the infographic below, it's that people are deeply interested in knowing about their bodies and eager to take action to improve health and wellness.

Drawing from several sources, Career Glider, which has created the infographic, highlights the fact that consumer will sport almost 112 million wearables by 2018 compared to the 19 million forecast as wearables sales for this year. And a whopping 70% of those will be to track fitness. Millennials and Gen X-ers are most likely to be users of wearable tech as the infographic shows below.

While the consumer wearables market is exploding, it's doubtful whether sales of wearables...

July 8th, 2014
0

3-D printing can create medical devices that can save and improve lives, but regulators are holding up progress. 

By Justin Coutu

Ever since Garrett Peterson was born, his parents have had to watch him suddenly stop breathing. Garrett was born with a trachea so weak that the littlest things make it collapse, cutting off his ability to breathe. So the Petersons contacted Dr. Glenn Green at the University of Michigan, who specializes in conditions like Garrett's. Dr. Green teamed up with Scott Hollister, a biomedical engineer who runs the university's 3-D printing lab, to create a remarkable solution to Garrett's problem—a device that will hold open Garrett's windpipe until it's strong enough to work on its own.

First, they took a CT scan of Garrett's windpipe, so they could make a...

July 3rd, 2014
0

                          Omar Ishrak

Medtronic CEO Omar Ishrak is certainly a man with a vision for the mighty medtech multinational he helms—and he’s systematically making it a reality. 

The company’s announced acquisition of Covidien for a staggering $42.9 billion promptly elicited grumbling about layoffs, offshoring, and the potential impact on the American economy in addition to sparking a fierce debate about the practice of tax inversion. But the focus on tax savings and increased cash flow has eclipsed the fact that Medtronic’s acquisition of Covidien neatly checks all of...

July 1st, 2014
1